When using an AR cut-off value of 25%, the mean UGT2B17 nuclear expression is 38% (95% CI: 29–46) vs 57% (95% CI: 50–64) in the AR < 25% vs AR ≥ 25% tumours, respectively (P = 0.0003). This evidence concerns the gene UGT2B17 and neoplasm.